These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 30791230)

  • 1. Efficiency of ultrafiltration/diafiltration in removing organic and elemental process equipment related leachables from biological therapeutics.
    Sun B; Hadidi M; Santiago Nuñez J; Song B; Tumambac GE; Wong K; Kalinowski G; Hathcock JJ
    Biotechnol Prog; 2024; 40(1):e3400. PubMed ID: 37964726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-criteria manufacturability indices for ranking high-concentration monoclonal antibody formulations.
    Yang Y; Velayudhan A; Thornhill NF; Farid SS
    Biotechnol Bioeng; 2017 Sep; 114(9):2043-2056. PubMed ID: 28464235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histidine as a versatile excipient in the protein-based biopharmaceutical formulations.
    Lv JY; Ingle RG; Wu H; Liu C; Fang WJ
    Int J Pharm; 2024 Jul; ():124472. PubMed ID: 39013532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of monoclonal antibodies. 1. Phase behavior and protein-protein interactions.
    Lewus RA; Levy NE; Lenhoff AM; Sandler SI
    Biotechnol Prog; 2015; 31(1):268-76. PubMed ID: 25378269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining Scattering Experiments and Colloid Theory to Characterize Charge Effects in Concentrated Antibody Solutions.
    Gulotta A; Polimeni M; Lenton S; Starr CG; Stradner A; Zaccarelli E; Schurtenberger P
    Mol Pharm; 2024 May; 21(5):2250-2271. PubMed ID: 38661388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of ultra- and diafiltration processes by Kalman-filtered Raman measurements.
    Rolinger L; Hubbuch J; Rüdt M
    Anal Bioanal Chem; 2023 Feb; 415(5):841-854. PubMed ID: 36651972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous Release of Silver Ions and 10-Undecenoic Acid from Silver Iron-Oxide Nanoparticles Impregnated Membranes.
    Nechifor G; Grosu AR; Ferencz Dinu A; Tanczos SK; Goran A; Grosu VA; Bungău SG; Păncescu FM; Albu PC; Nechifor AC
    Membranes (Basel); 2022 May; 12(6):. PubMed ID: 35736264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for high-concentration drug substance manufacturing to facilitate subcutaneous administration: A review.
    Holstein M; Hung J; Feroz H; Ranjan S; Du C; Ghose S; Li ZJ
    Biotechnol Bioeng; 2020 Nov; 117(11):3591-3606. PubMed ID: 32687221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass Balance Model with Donnan Equilibrium Accurately Describes Unusual pH and Excipient Profiles during Diafiltration of Monoclonal Antibodies.
    Baek Y; Singh N; Arunkumar A; Borwankar A; Zydney AL
    Biotechnol J; 2019 Jul; 14(7):e1800517. PubMed ID: 30791230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mechanistic model to account for the Donnan and volume exclusion effects in ultrafiltration/diafiltration process of protein formulations.
    Yu Z; Moomaw JF; Thyagarajapuram NR; Geng SB; Bent CJ; Tang Y
    Biotechnol Prog; 2021 Mar; 37(2):e3106. PubMed ID: 33289341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Small-Scale Process for Predicting Donnan and Volume Exclusion Effects During Ultrafiltration/Diafiltration Process Development.
    Abel J; Kosky A; Ball N; Bacon H; Kaushik R; Kleemann GR
    J Pharm Sci; 2018 May; 107(5):1296-1303. PubMed ID: 29339134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theoretical analysis of excipient concentrations during the final ultrafiltration/diafiltration step of therapeutic antibody.
    Miao F; Velayudhan A; DiBella E; Shervin J; Felo M; Teeters M; Alred P
    Biotechnol Prog; 2009; 25(4):964-72. PubMed ID: 19569193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic model of pH and excipient concentration during ultrafiltration and diafiltration processes of therapeutic antibodies.
    Ladwig JE; Zhu X; Rolandi P; Hart R; Robinson J; Rydholm A
    Biotechnol Prog; 2020 Sep; 36(5):e2993. PubMed ID: 32185869
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.